The study demonstrated that EC could be one of the sensitive tumor types, as CDK4 was shown to have higher expression compared to CDK6 in various reproductive organ systems, where abemaciclib has a higher potency against CDK4 compared to CDK6 [37]. Here, CDK4 is linked to neoplasm.